Impact of prescription size on statin adherence and cholesterol levels

Table 3 Multivariate Predictors of Final Cholesterol Value (mg/dL)

	Parameter Estimate (standard error)	PValue
Intercept*	175.36 (2.78)	<0.001
Age (per 10 year increase)	-5.79 (0.77)	<0.001
Female versus Male	12.60 (1.65)	<0.001
Race (Hispanic versus White)	-1.46 (1.97)	0.46
Race (Black versus White)	-0.01 (2.44)	0.99
Race (Other versus White)	2.30 (3.38)	0.50
Mostly 30 Days Supply	3.20 (1.91)	0.09
<80% adherent	17.23 (1.64)	<0.001
$0 Co-pay and uninsured	-3.18 (2.14)	0.14
> $0 Co-pay and insured	3.01 (3.19)	0.35
> $0 Co-pay and uninsured	10.48 (3.09)	<0.001

* Intercept is predicted cholesterol for a 50 year old white insured male with no co-payment, receiving mostly 60 day supply of statin medications, and achieving or exceeding 80% adherence. R² = 0.08

ISSN: 1472-6963